Baijin Life Science Holdings Ltd
01466
Company Profile
Business description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
Contact
66 Gloucester Road
Office B, 9/F Pico Tower
Wanchai
Hong Kong
HKGT: +852 36112188
Sector
Consumer Cyclical
Stock type
Cyclical
Industry
Luxury Goods
Fiscal Year End
31 March 2026
Employees
79
Stocks News & Analysis
stocks
The best way to get rich and retire early
This goes through the different options including shares, property and business ownership and declares a winner, as well as outlining the mindset needed to earn enough to never have to work again.
stocks
Investors overly negative on cheap ASX share
We cut our fair value by 26% but the market has overreacted.
stocks
Overvalued US AI play reports earnings
Strong earnings with high projected growth but price is too rich.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,022.40 | 1.20 | -0.01% |
| CAC 40 | 8,168.15 | 56.13 | 0.69% |
| DAX 40 | 24,490.41 | 139.29 | 0.57% |
| Dow JONES (US) | 48,400.59 | 61.34 | -0.13% |
| FTSE 100 | 9,940.71 | 74.18 | 0.75% |
| HKSE | 25,854.60 | 219.37 | 0.86% |
| NASDAQ | 23,475.81 | 1.46 | 0.01% |
| Nikkei 225 | 50,339.48 | 187.44 | -0.37% |
| NZX 50 Index | 13,548.13 | 22.14 | 0.16% |
| S&P 500 | 6,906.23 | 0.49 | 0.01% |
| S&P/ASX 200 | 8,717.10 | 4.10 | -0.05% |
| SSE Composite Index | 3,965.12 | 0.16 | -0.00% |